Funder: National Institutes of Health

Due Dates: June 16, 2025 (New) | July 16, 2025 (Renewal/Resubmission/Revision) | October 16, 2025 (New) | November 16, 2025 (Renewal/Resubmission/Revision) | February 16, 2026 (New) | March 16, 2026 (Renewal/Resubmission/Revision)

Funding Amounts: Up to $100,000 in direct costs per year for up to 2 years (max $200,000 direct costs total)

Summary: Supports early-stage and established researchers (new to AD/ADRD) in pilot projects to advance prevention, diagnosis, treatment, or care for Alzheimer's disease and related dementias.

Key Information: Applicants must not have held a major NIH award in AD/ADRD; at least half of awards are expected to go to early stage investigators.